Table 3.

Adjusted hazard ratios/odds ratios and 95% confidence interval for primary outcome by race (adjusted for age, gender, history of MI, heart failure, ancestry) and the p-value for SNP*treatment (calcium channel blocker treatment or beta blocker treatment strategy) interaction. The alleles shown in parentheses are the minor alleles.

	Caucasians			African Americans			Hispanics
	HR/OR§	p value	SNP*Treatment p value	HR/OR	p value	SNP*Treatment p value	HR/OR	p value	SNP*Treatment p value
rs2357928 (G allele)	0.72 (0.52-1.01)	0.06	0.002*	0.45 (0.20-1.0)	0.049	0.32	0.58 (0.34-1.01)	0.054	0.049
rs11014166 (T allele)	0.91 (0.57-1.45)	0.68	0.4	1.03 (0.59-1.79)	0.91	0.47	0.52 (0.24-1.13)	0.097	0.16
rs61839258 (T allele)	1.13 (0.77-1.66)	0.54	0.54	0.16 (0.03-1.04)	0.055	0.98	1.36 (0.64-2.92)	0.43	0.43
rs7069292 (C allele)	1.01 (0.74-1.38)	0.97	0.24	0.75 (0.33-1.69)	0.48	0.37	0.88 (0.51-1.52)	0.65	0.46

^§HR: hazard ratios reported for rs23579278 and rs11014166 per each minor allele; OR: odds ratios reported for rs61839258 and rs7069292 for each minor allele.

^*The false discovery rate adjusted p value = 0.024.